Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1 - 25 of 1614 in total
Investigational
Matched Name: … IKT-001Pro
Matched Salts name: … IKT-001 Mesylate …
Experimental
Withdrawn
Matched Name: … BMN-046
EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.
Investigational
Matched Synonyms: … EF 022
Matched Name: … EF-022
Matched Description: … EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic …
MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD)...
Investigational
Matched Name: … MDX-018
Matched Description: … MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin- …
Investigational
Matched Name: … SNS-032
AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal studies to enhance memory and to reverse memory deficits in severely impaired animals that do not respond to Neotrofin. AIT-034 does not induce the production of NGF, and its mechanism of action is therefore...
Investigational
Matched Name: … AIT-034
Matched Description: … AIT-034 is a distinct chemical analog of hypoxanthine and pyrollidone that has been demonstrated in animal ... AIT-034 does not induce the production of NGF, and its mechanism of action is therefore believed to be ... There is some evidence that AIT-034 could complement Neotrofin as a treatment for Alzheimer's disease …
Experimental
Matched Name: … K-00546
MK0249 has been used in trials studying the treatment of Hypopnea Syndrome, Alzheimer's Disease, Paranoid Schizophrenia, Sleep Apnea, Obstructive, and Excessive Daytime Sleepiness, among others.
Investigational
Matched Name: … MK-0249
OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.
Investigational
Matched Name: … OSI-027
Matched Description: … OSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma. …
AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Matched Name: … AKN-028
Matched Description: … AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia. …
MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.
Investigational
Matched Name: … MGD-024
Matched Description: … MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule. …
ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for cancer.
Investigational
Matched Synonyms: … ENB 003
Matched Name: … ENB-003
Matched Description: … ENB-003 is a selective and potent inhibitor of the endothelin B receptor (ETBR) being investigated for …
MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Investigational
Matched Name: … MK-0482
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …
KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.
Investigational
Matched Name: … KF-0210
Matched Description: … KF-0210 is a small molecule developed by Keythera Pharmaceuticals. …
Investigational
Matched Synonyms: … VK-0214
Matched Name: … VK-0214
Investigational
Matched Synonyms: … ALX-009
Matched Name: … ALX-009
Investigational
Matched Name: … BSG-005
APL-030 is a orally-active small molecule inhibitor of GCN2.
Investigational
Matched Name: … APL-030
Matched Description: … APL-030 is a orally-active small molecule inhibitor of GCN2. …
EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.
Investigational
Matched Name: … EHT 0202
Matched Description: … EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics. …
AZD0328 has been used in trials studying the treatment and basic science of Schizophrenia and Alzheimer's Disease.
Investigational
Matched Name: … AZD-0328
GDC-0152 has been used in trials studying the treatment of Solid Cancers.
Investigational
Matched Name: … GDC-0152
Matched Description: … GDC-0152 has been used in trials studying the treatment of Solid Cancers. …
Investigational
Matched Name: … ETBX-021
PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.
Investigational
Matched Name: … PLG-0206
Matched Description: … PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections …
OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells.
Investigational
Matched Name: … OSSM-007
Matched Description: … OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells. …
GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
Investigational
Matched Name: … GLPG-0259
Matched Description: … GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability …
Displaying drugs 1 - 25 of 1614 in total